August 3, 2021
Akoya Biosciences to Present at the Canaccord 41st Annual Growth Conference
MARLBOROUGH, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be virtually participating in the Canaccord 41st Annual Growth Conference. Brian McKelligon, CEO is scheduled to present on Wednesday,...

Continue Reading
July 20, 2021
Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021
MARLBOROUGH, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will release financial results for the second quarter of 2021 after the market close on Tuesday, August 10, 2021....

Continue Reading
July 19, 2021
Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer
Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company’s Phenoptics™ multiplex immunofluorescence (mIF) platform, for clinical and translational research MARLBOROUGH, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc.,...

Continue Reading
June 29, 2021
Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I²) Network
Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging MARLBOROUGH, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced partnerships with premier...

Continue Reading
June 25, 2021
Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors
MARLBOROUGH, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company ® , today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors. “I am delighted to join the board of directors of Akoya, a company...

Continue Reading
June 15, 2021
Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities
CODEX’s single-cell, multiplex imaging capabilities to be included in Chan Zuckerberg Initiative grantee toolkit to help fuel the next wave of biological discoveries MARLBOROUGH, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today...

Continue Reading
June 10, 2021
Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy and Pathology
Investigators at Johns Hopkins University (JHU) used AstroPath to identify and validate biomarkers for accurate prediction of long-term response to immune checkpoint inhibitors in advanced melanoma AstroPath combines JHU’s famed 3D sky mapping algorithms for managing astronomical-scale datasets...

Continue Reading
June 9, 2021
Akoya Set to Join Russell 3000® Index
MARLBOROUGH, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, is set to join the broad-market Russell 3000 ®  Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on...

Continue Reading
June 4, 2021
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology
Partnership aims to leverage spatial biology data, generated on Akoya’s Phenoptics™ platform, to inform and guide drug development programs MARLBOROUGH, Mass., June 04, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today announced a collaboration...

Continue Reading
June 2, 2021
Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications
Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials MARLBOROUGH, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today...

Continue Reading
Displaying 1 - 10 of 20

Search Investor Relations